The power to make common fund orders in class actions is a question before the High Court a second time, but the justices aren’t likely to quell the conflict simmering in the courts below, at least until they have a concrete order before them.
Law firm Thomson Geer has bolstered the ranks of its media team with the recruitment of News Corp senior litigation counsel Marlia Saunders to its Sydney office.
The lead applicants in a class action against two CBA units over allegedly excessive insurance premiums have been ordered to amend their pleadings to expand the group definition and add more detail to their claims.
Mineralogy is seeking declarations that its 2014 financial statements were true and fair in a court case ASIC has called a “collateral attack” on criminal proceedings brought against Clive Palmer over $12 million spent on his political aspirations.
Victorian public healthcare provider Peninsula Health has hit back at an underpayments class action brought by junior doctors, saying it was up to them to seek authorisation and payment for any overtime hours worked.
A judge has criticised the Australian Broadcasting Corporation for āill advisedā redactions in documents produced in a dispute between the producers of the consumer affairs television series The Checkout.
Billionaire Clive Palmer has agreed to pay part of Universal Music’s costs on an indemnity basis, after a judge found he infringed substantial parts of the copyright for Twister Sister’s rock anthem ‘We’re Not Gonna Take It’ and ordered him to pay $1.5 million in damages.
Ben Roberts-Smith has admitted that he owns a glass replica of the prosthetic leg belonging to a man he killed in Afghanistan, as trial in his defamation case entered its third week.
The āhustle and bustleā of defending companies in complex litigation does not faze Colin Biggers & Paisleyās Adrian Konstantinidis, so when the COVID-19 pandemic struck on the eve of one of the most complicated series of cases in Australia, he and his firm were ready.
The Full Federal Court has upheld US biotech company Sequenom’sĀ patent for a noninvasive prenatal genetic test, rejecting rival Ariosa Diagnostic’s argument that the patent merely described a way to extract incorporeal genetic information.